Trinity Bio ADR (TRIB)
0.8260 +0.0055 (+0.67%) 01/17/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 0.8250 -0.0010 (-) 01/17/25
for Fri, Jan 17th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 56,832 | 62,521 | 92,965 | 101,980 | 90,435 |
Cost of Goods | 37,382 | 45,253 | 54,888 | 53,400 | 52,315 |
Gross Profit | 19,450 | 17,268 | 38,077 | 48,580 | 38,120 |
Operating Expenses | 46,877 | 36,870 | 32,340 | 48,898 | 62,547 |
Operating Income | -27,045 | -19,349 | 6,625 | 82 | -24,112 |
Interest Expense | 11,053 | 24,734 | 7,097 | 6,751 | 6,582 |
Other Income | 1,171 | 303 | 1,223 | 36 | 697 |
Pre-tax Income | -36,927 | -43,780 | 751 | -6,633 | -29,997 |
Income Tax | -59 | -194 | -178 | -620 | -1,006 |
Net Income Continuous | -36,868 | -43,586 | 929 | -6,013 | -28,991 |
Net Income Discontinuous | 12,850 | 2,577 | -54 | -375 | 77 |
Net Income | $-24,018 | $-41,009 | $875 | $-6,388 | $-28,914 |
EPS Basic Total Ops | -3.14 | -6.08 | 0.20 | -1.55 | -6.90 |
EPS Basic Continuous Ops | -4.82 | -6.46 | 0.21 | -1.44 | -6.92 |
EPS Basic Discontinuous Ops | 1.68 | 0.38 | -0.01 | -0.09 | 0.02 |
EPS Diluted Total Ops | -3.14 | -6.08 | 0.20 | -1.55 | -6.90 |
EPS Diluted Continuous Ops | -4.82 | -6.46 | 0.21 | -1.15 | -6.92 |
EPS Diluted Discontinuous Ops | 1.68 | 0.38 | -0.01 | -0.07 | 0.02 |
EPS Diluted Before Non-Recurring Items | -3.37 | -5.25 | 1.75 | 3.75 | -0.15 |
EBITDA(a) | $-25,268 | $-17,016 | $9,369 | $3,159 | $-19,218 |